Evidence map›Paper›PMID 38645031›Full record

ArticleResearch square2024

Phosphorylation-Driven Epichaperome Assembly: A Critical Regulator of Cellular Adaptability and Proliferation.

Seth W McNutt, Tanaya Roychowdhury, Chiranjeevi Pasala, Hieu T Nguyen, Daniel T Thornton, Sahil Sharma, Luke Botticelli, Chander S Digwal, Suhasini Joshi, Nan Yang and 22 more

Open access · greenAbstract readPreprint
In one paragraph

Article in Research square, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

32 authors at 9 institutions in 4 countries.

Seth W McNuttDepartment of Molecular, Cellular & Biomedical Sciences, University of New Hampshire, Durham, NH 03824, USA.
Tanaya RoychowdhuryChemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Chiranjeevi PasalaChemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Hieu T NguyenDepartment of Molecular, Cellular & Biomedical Sciences, University of New Hampshire, Durham, NH 03824, USA.
Daniel T ThorntonDepartment of Molecular, Cellular & Biomedical Sciences, University of New Hampshire, Durham, NH 03824, USA.
Sahil SharmaChemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.ORCID 0000-0001-7281-9224
Luke BotticelliDepartment of Molecular, Cellular & Biomedical Sciences, University of New Hampshire, Durham, NH 03824, USA.
Chander S DigwalChemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.ORCID 0000-0001-8784-1096
Suhasini JoshiChemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Nan YangDepartment of Molecular, Cellular & Biomedical Sciences, University of New Hampshire, Durham, NH 03824, USA.
Palak PanchalChemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Souparna ChakrabartyChemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Sadik BayChemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.ORCID 0000-0001-8089-1330
Vladimir MarkovAntitumor Assessment Core Facility, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Charlene KwongAntitumor Assessment Core Facility, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Jeanine LisantiAntitumor Assessment Core Facility, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Sun Young ChungChemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.ORCID 0000-0002-3381-919X
Stephen D GinsbergDepartments of Psychiatry, Neuroscience & Physiology & the NYU Neuroscience Institute, NYU Grossman School of Medicine, New York, NY, 10016, USA.ORCID 0000-0002-1797-4288
Pengrong YanChemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Elisa DeStanchinaAntitumor Assessment Core Facility, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Adriana CorbenDepartment of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
Shanu ModiDepartment of Medicine, Division of Solid Tumors, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Mary AlpaughChemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.ORCID 0000-0002-0008-2718
Giorgio ColomboDepartment of Chemistry, University of Pavia, via Taramelli 12, 27100 Pavia, Italy.ORCID 0000-0002-1318-668X
Hediye Erdjument-BromageDepartment of Neuroscience and Physiology and Neuroscience Institute, NYU Grossman School of Medicine, New York, NY, 10016, USA.
Thomas A NeubertDepartment of Neuroscience and Physiology and Neuroscience Institute, NYU Grossman School of Medicine, New York, NY, 10016, USA.
Robert J ChalkleyMass Spectrometry Facility, University of California, San Francisco, California 94143, USA.ORCID 0000-0002-9757-7302
Peter R BakerMass Spectrometry Facility, University of California, San Francisco, California 94143, USA.
Alma L BurlingameMass Spectrometry Facility, University of California, San Francisco, California 94143, USA.ORCID 0000-0002-8403-7307
Anna RodinaChemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.ORCID 0000-0002-3894-6438
Gabriela ChiosisChemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.ORCID 0000-0003-0486-6920
Feixia ChuDepartment of Molecular, Cellular & Biomedical Sciences, University of New Hampshire, Durham, NH 03824, USA.ORCID 0000-0002-3209-8095
Memorial Sloan Kettering Cancer Center · USUniversity of New Hampshire · USNeurosciences Institute · USUniversity of New Hampshire at Manchester · USNathan Kline Institute for Psychiatric Research · USUniversidad Católica de Santa Fe · ARUniversity of California, San Francisco · USUniversity of California System · USUniversity of Pavia · IT

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI SELWYN M VICKERS · 1985 to 2026
$347.4M
TLR-TRIF mediated induction of GLI3 modulates innate inflammatory responsesP20GM113131 · NIGMS · UNIVERSITY OF NEW HAMPSHIRE · PI Sean Stoddart Coleman Edington · 2017 to 2026
$22.8M
Project 3: Structural Basis for grp94 Drug Development and Chaperone FunctionP01CA186866 · NCI · OHIO STATE UNIVERSITY · PI LI, ZIHAI · 2015 to 2019
$6.7M
Impact of sex differences on the trajectory of interactome dysfunctions across the AD spectrumR01AG074004 · NIA · SLOAN-KETTERING INST CAN RESEARCH · PI CHIOSIS, GABRIELA, GINSBERG, STEPHEN D · 2021 to 2025
$6.0M
Chaperome networks in Alzheimer's diseaseR01AG067598 · NIA · SLOAN-KETTERING INST CAN RESEARCH · PI ARANCIO, OTTAVIO, CHIOSIS, GABRIELA · 2021 to 2025
$5.9M
Selective interactome vulnerability across the Alzheimer’s disease spectrumR01AG072599 · NIA · SLOAN-KETTERING INST CAN RESEARCH · PI GABRIELA CHIOSIS, STEPHEN D GINSBERG · 2023 to 2026
$5.4M
[18F]-PU-AD epichaperome PET imaging probeRF1AG071805 · NIA · SLOAN-KETTERING INST CAN RESEARCH · PI CHIOSIS, GABRIELA, DUNPHY, MARK P. · 2022 to 2025
$4.8M
Neuropathology and inflammation in a nonhuman primate model of insulin resistance/metabolic syndromeR01AG085572 · NIA · UNIVERSITY OF CALIFORNIA AT DAVIS · PI STEPHEN D GINSBERG, PETER J HAVEL · 2024 to 2026
$3.8M
Small molecule Hsp90 inhibitors in AD treatmentU01AG032969 · NIA · SLOAN-KETTERING INST CAN RESEARCH · PI CHIOSIS, GABRIELA · 2010 to 2014
$3.5M
Biomarkers for predicting response to Hsp90 therapyR01CA172546 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI CHIOSIS, GABRIELA, DUNPHY, MARK P. · 2013 to 2017
$2.9M
A chemical chaperomics platform for ADR56AG061869 · NIA · SLOAN-KETTERING INST CAN RESEARCH · PI CHIOSIS, GABRIELA · 2018 to 2019
$1.8M
Selective interactome vulnerability across the Alzheimer’s disease spectrumR56AG072599 · NIA · SLOAN-KETTERING INST CAN RESEARCH · PI CHIOSIS, GABRIELA, GINSBERG, STEPHEN D · 2021 to 2021
$1.2M
NCI NIH HHS P01 CA186866NCI NIH HHS P30 CA008748NCI NIH HHS R01 CA172546NIA NIH HHS R01 AG067598NIA NIH HHS R01 AG072599NIA NIH HHS R01 AG074004NIA NIH HHS R01 AG085572NIA NIH HHS R56 AG061869NIA NIH HHS R56 AG072599NIA NIH HHS RF1 AG071805NIA NIH HHS U01 AG032969NIGMS NIH HHS P20 GM113131
6 · The paper itself

Abstract

The intricate protein-chaperone network is vital for cellular function. Recent discoveries have unveiled the existence of specialized chaperone complexes called epichaperomes, protein assemblies orchestrating the reconfiguration of protein-protein interaction networks, enhancing cellular adaptability and proliferation. This study delves into the structural and regulatory aspects of epichaperomes, with a particular emphasis on the significance of post-translational modifications in shaping their formation and function. A central finding of this investigation is the identification of specific PTMs on HSP90, particularly at residues Ser226 and Ser255 situated within an intrinsically disordered region, as critical determinants in epichaperome assembly. Our data demonstrate that the phosphorylation of these serine residues enhances HSP90's interaction with other chaperones and co-chaperones, creating a microenvironment conducive to epichaperome formation. Furthermore, this study establishes a direct link between epichaperome function and cellular physiology, especially in contexts where robust proliferation and adaptive behavior are essential, such as cancer and stem cell maintenance. These findings not only provide mechanistic insights but also hold promise for the development of novel therapeutic strategies targeting chaperone complexes in diseases characterized by epichaperome dysregulation, bridging the gap between fundamental research and precision medicine.

Identifiers

PMID38645031
PMCPMC11030525
OpenAlexW4393868255

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.